RXRX
Recursion Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.63
+5.52%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.53x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.14x
- Net debt / EBITDA
- 1.09x
Liquidity & coverage
- Current ratio
- 5.03x
- Quick ratio
- 5.03x
- Cash ratio
- 4.55x
- Interest coverage
- -364.62x
- EBITDA / interest
- -297.89x
- Working capital
- $483.6M
Cash & dividend
- FCF / debt
- -5.72x
- Cash flow / debt
- -5.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026